US Stock MarketDetailed Quotes
VRCA Verrica Pharmaceuticals
- 0.785
- -0.018-2.19%
Trading Dec 13 10:04 ET
71.09MMarket Cap-0.43P/E (TTM)
0.847High0.770Low97.02KVolume0.790Open0.803Pre Close77.44KTurnover0.23%Turnover RatioLossP/E (Static)90.56MShares11.41052wk High-2.09P/B33.86MFloat Cap0.70452wk Low--Dividend TTM43.13MShs Float23.290Historical High--Div YieldTTM9.58%Amplitude0.704Historical Low0.798Avg Price1Lot Size
Heat List
US
Overall
Symbol
Price
% Chg
No Data
Verrica Pharmaceuticals Stock Forum
Verrica Pharmaceuticals Announces that Development Partner Torii Pharmaceutical Files New Drug Application of TO-208 the Treatment of Molluscum Contagiosum in Japan
Friday, 6th December at 8:00 am
WEST CHESTER, Pa., Dec. 06, 2024 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. ("Verrica" or the "Company") (NASDAQ: VRCA), a dermatology therapeutics company developing medications for skin diseases requiring medical interventions, today announced its develop...
loading...
Buying some in speculation and feeling some green days ahead due to presese of signal of uptrend and thinnner negetive free cash flow shrinkage year round no risk no substantial rewards looks like 5 year bottom rebounding
loading...
WEST CHESTER, Pa., Oct. 24, 2024 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica” or the “Company”) (Nasdaq: VRCA), a dermatology therapeutics company developing medications for skin diseases requiring medical interventions, today announced the acceptanc...
Verrica Pharmaceuticals Announces Restructuring of Commercial Organization
Company significantly reduces cost structure with a realigned sales, marketing and operational infrastructure
- Sales and marketing efforts to focus on pediatricians and expand access beyond dermatologists
WEST CHESTER, Pa., Oct. 02, 2024 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. ("Verrica" or the "Company") (NASDAQ:VRCA), a dermatology therapeutics company developing med...
No comment yet